Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors

Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors

US Patent 10821162 · Granted Nov 3, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of car and bite technology coupled with an SCFV from an antibody against hum2024
Use of car and bite technology coupled with an SCFV from an antibody against hum2024
Transgenic macrophages, chimeric antigen receptors, and associated methods2024
Macrophage CAR (MOTO-CAR) in immunotherapy2022
Macrophage CAR (MOTO-CAR) in immunotherapy2022
Use of car and bite technology coupled with an SCFV from an antibody against hum2021
Use of car and bite technology coupled with an SCFV from an antibody against hum2021
Transgenic macrophages, chimeric antigen receptors, and associated methods2021
Use of car and bite technology coupled with an ScFv from an antibody against hum2020
Use of car and bite technology coupled with an ScFv from an antibody against hum2020
Use of car and bite technology coupled with an scFv from an antibody against hum2019
Use of car and bite technology coupled with an scFv from an antibody against hum2019